GenMark Diagnostics' Q4 Revenues Rise 34 Percent | GenomeWeb

NEW YORK (GenomeWeb) – GenMark Diagnostics reported today after the close of the market that its fourth quarter revenues rose 34 percent year over year.

For the three months ended Dec. 31, 2015, the company reported revenues of $13.2 million compared to $9.8 million in Q4 2014, beating analysts' consensus estimate of $12.3 million for the quarter. Product sales accounted for almost all of the revenue in the quarter, and the company said it placed 17 additional XT-8 analyzers in end-user laboratories for a total of 633 analyzers in the US market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.